View Item 

Show simple item record

Elara: A Phase 2 Trial Investigating The Efficacy And Safety Of Tisagenlecleucel In Adult Patients With Refractory/Relapsed Follicular Lymphoma
dc.contributor.authorDickinson, M.
dc.contributor.authorPopplewell, L.
dc.contributor.authorKolstad, A.
dc.contributor.authorHo, P.J.
dc.contributor.authorTeshima, T.
dc.contributor.authorDreyling, M.
dc.contributor.authorSchuster, S.
dc.contributor.authorThieblemont, C.
dc.contributor.authorGhosh, M.
dc.contributor.authorRiedell, P.
dc.contributor.authorYateman, N.
dc.contributor.authorLehnhoff, K.
dc.contributor.authorLawniczek, T.
dc.contributor.authorPacaud, L.
dc.contributor.authorFowler, N.
dc.date.accessioned2019-06-20T17:04:11Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2019-06-20T17:04:11Z
dc.date.issued2019-06
dc.identifier.citationDickinson, M.; Popplewell, L.; Kolstad, A.; Ho, P.J.; Teshima, T.; Dreyling, M.; Schuster, S.; Thieblemont, C.; Ghosh, M.; Riedell, P.; Yateman, N.; Lehnhoff, K.; Lawniczek, T.; Pacaud, L.; Fowler, N. (2019). "Elara: A Phase 2 Trial Investigating The Efficacy And Safety Of Tisagenlecleucel In Adult Patients With Refractory/Relapsed Follicular Lymphoma." Hematological Oncology 37(S2): 559-560.
dc.identifier.issn0278-0232
dc.identifier.issn1099-1069
dc.identifier.urihttps://hdl.handle.net/2027.42/149492
dc.publisherWiley Periodicals, Inc.
dc.titleElara: A Phase 2 Trial Investigating The Efficacy And Safety Of Tisagenlecleucel In Adult Patients With Refractory/Relapsed Follicular Lymphoma
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOtolaryngology
dc.subject.hlbsecondlevelNeurosciences
dc.subject.hlbsecondlevelObstetrics and Gynecology
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbsecondlevelOphthalmology
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/149492/1/hon6_2632.pdf
dc.identifier.doi10.1002/hon.6_2632
dc.identifier.sourceHematological Oncology
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hon6_2632.pdf
Size:
157.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.